Intuitive Surgical (ISRG) Other Non-Current Liabilities (2009 - 2026)
Intuitive Surgical (ISRG) recorded quarterly Other Non-Current Liabilities of $602.8 million in Q1 2026, up 18.01% quarter-over-quarter from $510.8 million in Q4 2025, and up 27.01% on a YoY basis from $474.6 million in Q1 2025.
Intuitive Surgical (ISRG) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Intuitive Surgical's Other Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $602.8 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 27.01% year-over-year to $602.8 million; the TTM figure through Mar 2026 stood at $602.8 million (up 27.01% YoY), while the FY2025 annual figure was $510.8 million, up 9.08% from the prior year.
- Other Non-Current Liabilities was $602.8 million for Q1 2026 at Intuitive Surgical, up from $510.8 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $602.8 million in Q1 2026 to a low of $365.9 million in Q2 2024.
- Historically, Other Non-Current Liabilities has averaged $449.8 million across 5 years, with a median of $447.8 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities decreased 12.25% in 2023, then jumped 41.43% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $439.3 million in 2022, then decreased by 12.25% to $385.5 million in 2023, then gained by 21.48% to $468.3 million in 2024, then advanced by 9.08% to $510.8 million in 2025, then rose by 18.01% to $602.8 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $602.8 million (Q1 2026), $510.8 million (Q4 2025), and $506.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 602.80 Mn |
| Dec 31, 2025 | 510.80 Mn |
| Sep 30, 2025 | 506.50 Mn |
| Jun 30, 2025 | 517.50 Mn |
| Mar 31, 2025 | 474.60 Mn |
| Dec 31, 2024 | 468.30 Mn |
| Sep 30, 2024 | 389.10 Mn |
| Jun 30, 2024 | 365.90 Mn |
| Mar 31, 2024 | 406.50 Mn |
| Dec 31, 2023 | 385.50 Mn |
| Sep 30, 2023 | 412.80 Mn |
| Jun 30, 2023 | 405.20 Mn |
| Mar 31, 2023 | 451.60 Mn |
| Dec 31, 2022 | 439.30 Mn |
| Sep 30, 2022 | 453.40 Mn |
| Jun 30, 2022 | 447.80 Mn |
| Mar 31, 2022 | 409.30 Mn |
| Dec 31, 2021 | 453.70 Mn |
| Sep 30, 2021 | 447.80 Mn |
| Jun 30, 2021 | 412.90 Mn |